US industry groups blast FDA guidance on "least burdensome"
This article was originally published in Clinica
Executive Summary
US industry has issued a scathing assessment of the FDA's September 1 guidance document for implementing the least burdensome Provision of the FDA Modernization Act of 1997 (FDAMA).